QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
Free Trial

Sorrento Therapeutics (SRNE) SEC Filings & 10K Form

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free srne Stock Alerts
$0.04
+0.01 (+21.21%)
(As of 04:05 PM ET)
Compare
Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsSocial MediaSustainability

Recent Sorrento Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
11/07/2023
3:34 PM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
4:31 PM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2023
3:15 PM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2023
4:16 PM		Celularity Inc (Issuer)
Celularity Inc (Issuer)
Sorrento Therapeutics (Reporting)
Sorrento Therapeutics, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
4:22 PM		Celularity Inc (Subject)
Celularity Inc (Subject)
Sorrento Therapeutics (Filed by)
Sorrento Therapeutics, Inc. (Filed by)
Form SC 13G/A
10/05/2023
4:26 PM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2023
3:49 PM		Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Sorrento Therapeutics (Filed by)
Sorrento Therapeutics, Inc. (Filed by)
Form SC 13D/A
09/26/2023
3:54 PM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
3:27 PM		Scilex Holding Co (Issuer)
Scilex Holding Co (Issuer)
Scilex Holding Co (Issuer)
Scilex Holding Co (Issuer)
Scilex Holding Co (Issuer)
Sorrento Therapeutics (Reporting)
Sorrento Therapeutics, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
8:51 PM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2023
4:25 PM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2023
10:20 AM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
7:59 PM		Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Sorrento Therapeutics (Filed by)
Sorrento Therapeutics, Inc. (Filed by)
Form SC 13D/A
08/01/2023
5:01 AM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2023
4:23 PM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form POS AM
07/13/2023
5:26 AM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2023
8:49 PM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
4:24 PM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form POS AM
06/15/2023
8:41 AM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2023
8:23 PM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
2:16 PM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2023
11:03 AM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2023
4:28 PM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form POS AM
05/08/2023
8:04 PM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form NT 10-Q
04/20/2023
4:26 PM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2023
11:08 AM		Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:SRNE) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Can't believe it's happening again
Manward Press
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The “Perfect Storm” for Gold
Gold Safe Exchange
1970’s computer coder issues shocking A.I. warning
TradeSmith
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
How to Know Which AI Company to Invest In… and When
Banyan Hill Publishing